In this activity, there are standards of care and government mandates documentation of prognostic indicators and staging which are constantly evolving new therapeutic approaches introduced or investigated through clinical trials for cancer. 

LINK:

OBJECTIVES: Upon completion of this activity, the participant should be able to:

1. Identify appropriate clinical and/or pathologic staging for improving knowledge to various forms of malignancy by discussion of national treatment guidelines.

2. Define and differentiate the various treatment and management options for pre and post-surgery cases

3. Recognize available and appropriate clinical trials and provide enrollment options

4. Differentiate and utilize the recommendations from current clinical guidelines/national treatment standards 

PLANNER/MODERATOR DISCLOSURE: The planners have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Kimberlee Martin at Kimberlee.Martin@BSWHealth.org